These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31262613)

  • 1. Clinical impact of using fluoroquinolone with low antimycobacterial activity on treatment delay in tuberculosis: Hospital-based and population-based cohort study.
    Lee MR; Lee CH; Wang JY; Lee SW; Ko JC; Lee LN
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):367-376. PubMed ID: 31262613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of gemifloxacin on the delay of tuberculosis treatment.
    Kim SY; Yim JJ; Park JS; Park SS; Heo EY; Lee CH; Chung HS; Kim DK
    J Korean Med Sci; 2013 Mar; 28(3):378-82. PubMed ID: 23486643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.
    Tseng YT; Chuang YC; Shu CC; Hung CC; Hsu CF; Wang JY
    Crit Care; 2012 Oct; 16(5):R207. PubMed ID: 23098258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients.
    Lee JY; Lee HJ; Kim YK; Yu S; Jung J; Chong YP; Lee SO; Choi SH; Shim TS; Kim YS; Woo JH; Kim SH
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4005-12. PubMed ID: 27090178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems.
    Jabeen K; Shakoor S; Hasan R
    Int J Infect Dis; 2015 Mar; 32():118-23. PubMed ID: 25809767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas.
    Wang JY; Hsueh PR; Jan IS; Lee LN; Liaw YS; Yang PC; Luh KT
    Thorax; 2006 Oct; 61(10):903-8. PubMed ID: 16809417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does radiographic evidence of prior pulmonary tubercular infection influence the choice of empiric antibiotics for community-acquired pneumonia in a tuberculosis-endemic area?
    Jeng YY; Lin YT; Huang LJ; Chen TL; Wang FD; Fung CP; Liu CY
    J Microbiol Immunol Infect; 2010 Oct; 43(5):386-94. PubMed ID: 21075705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic?
    Wang M; Fitzgerald JM; Richardson K; Marra CA; Cook VJ; Hajek J; Elwood RK; Bowie WR; Marra F
    Int J Tuberc Lung Dis; 2011 Aug; 15(8):1062-8. PubMed ID: 21740669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival in patients with severe tuberculosis after exposure to fluoroquinolones.
    Chiang SR; Shieh JM; Chen CH; Hsing SC; Wen SF; Wang JJ; Cheng KC; Chuang YC
    Infect Dis (Lond); 2016; 48(11-12):789-95. PubMed ID: 27329552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gemifloxacin (SB-265805, LB20304a): in vitro activity against over 6000 gram-positive pathogens from diverse geographic areas.
    Jones RN; Pfaller MA; Erwin ME
    Int J Antimicrob Agents; 2000 Aug; 15(3):227-30. PubMed ID: 10926446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of drug resistant destructive pulmonary tuberculosis: gemifloxacin and other fluoroquinolones clinical efficiency and tolerance at the end of initial phase of treatment].
    Petrenko VI; Radysh HV
    Lik Sprava; 2013 Dec; (8):55-63. PubMed ID: 25726677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
    Wu PF; Lin YT; Wang FD; Yang TC; Fung CP
    Infection; 2018 Jun; 46(3):365-373. PubMed ID: 29556979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolone resistance in renal isolates of Mycobacterium tuberculosis.
    Webster D; Long R; Shandro C; Pettipas J; Leblanc J; Davidson R; Fanning A
    Int J Tuberc Lung Dis; 2010 Feb; 14(2):217-22. PubMed ID: 20074414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin.
    Léophonte P; File T; Feldman C
    Respir Med; 2004 Aug; 98(8):708-20. PubMed ID: 15303634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of pulmonary MDR-TB: impacts of fluoroquinolone resistance and linezolid treatment.
    Jeong BH; Jeon K; Park HY; Kwon OJ; Lee KS; Kim HK; Choi YS; Kim J; Huh HJ; Lee NY; Koh WJ
    J Antimicrob Chemother; 2015 Nov; 70(11):3127-33. PubMed ID: 26203184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes of rifampin-sparing treatment in patients with pulmonary tuberculosis with rifampin-mono-resistance or rifampin adverse events: A retrospective cohort analysis.
    Park S; Jo KW; Lee SD; Kim WS; Shim TS
    Respir Med; 2017 Oct; 131():43-48. PubMed ID: 28947041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone resistance in non-multidrug-resistant tuberculosis-a surveillance study in New South Wales, Australia, and a review of global resistance rates.
    Ho J; Jelfs P; Sintchenko V
    Int J Infect Dis; 2014 Sep; 26():149-53. PubMed ID: 25086437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High fluoroquinolone MIC is associated with fluoroquinolone treatment failure in urinary tract infections caused by fluoroquinolone susceptible Escherichia coli.
    Rattanaumpawan P; Nachamkin I; Bilker WB; Roy JA; Metlay JP; Zaoutis TE; Lautenbach E;
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):25. PubMed ID: 28390438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis.
    Lee JH; Kim HJ; Kim YH
    J Korean Med Sci; 2017 Jan; 32(1):77-84. PubMed ID: 27914135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fluoroquinolone antibiotics leads to tuberculosis treatment delay in a South African gold mining community.
    Jeon CY; Calver AD; Victor TC; Warren RM; Shin SS; Murray MB
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):77-83. PubMed ID: 21276301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.